Table 2.

Results of clinical outcomes by treatment type

	n (%)	events	3yr PFS Prob	HR (95%CI)	p-value
Entire Cohort	43 (100)	6	0.89(0.80–1.00)	-	-
As-Treated Group*
RCHOP + radiation	10 (23)	1	1	Reference	-
RCHOP alone	16 (37)	1	0.93(0.82–1.00)	0.77(0.05–12.43)	0.85
RCHOP escalation	7 (16)	1	1	0.90(0.06–14.56)	0.94
DA-R-EPOCH	9 (21)	3	0.51(0.21–1.00)	12.71(0.81–199.95)	0.07
ITT RCHOP Cohort	n (%)	events	3-yr EFS/PFS Prob
EFS	26 (100)	11	0.57 (0.41–0.80)
PFS	26 (100)	1	0.94 (0.84–1.00)

Abbreviations: PFS: Progression-Free Survival; EFS: Event-Free Survival; ITT: Intention-to-Treat; yr: year; Prob: Probability, HR: Hazard Ratio

^*One patient with RCHOP+HIDAC was not listed